XRAY logo

DENTSPLY SIRONA Inc. Stock Price

NasdaqGS:XRAY Community·US$2.1b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 23 Fair Values set on narratives written by author

XRAY Share Price Performance

US$10.04
-6.07 (-37.68%)
US$14.54
Fair Value
US$10.04
-6.07 (-37.68%)
30.9% undervalued intrinsic discount
US$14.54
Fair Value
Price US$10.04
AnalystConsensusTarget US$14.54
yiannisz US$45.50
AnalystLowTarget US$10.00

XRAY Community Narratives

·
Fair Value US$14.54 30.9% undervalued intrinsic discount

Analysts Weigh Mixed Outlook for DENTSPLY SIRONA as Valuation and Guidance Adjusted

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
Fair Value
·
Fair Value US$45.5 77.9% undervalued intrinsic discount

Dentsply Sirona Stock: Dental Technology Built for Cycles, Not Headlines

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$10 0.4% overvalued intrinsic discount

Rising Cost Pressures And Market Shifts Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$45.5
77.9% undervalued intrinsic discount
Fair Value
Profit Margin
13.68%
Future PE
27.45x
Price in 2031
US$74.51
US$17
40.9% undervalued intrinsic discount
Profit Margin
9.69%
Future PE
12.17x
Price in 2029
US$22.4
US$10
0.4% overvalued intrinsic discount
Profit Margin
2.95%
Future PE
24.66x
Price in 2029
US$13.36

Trending Discussion

Updated Narratives

XRAY logo

Dentsply Sirona Stock: Dental Technology Built for Cycles, Not Headlines

Fair Value: US$45.5 77.9% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
XRAY logo

XRAY: New Tech Partnerships And Cost Discipline Will Support Future Upside

Fair Value: US$17 40.9% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
XRAY logo

XRAY: Execution Risks And Impairments Will Continue To Pressure Risk Reward

Fair Value: US$10 0.4% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with moderate growth potential.

0 Risks
3 Rewards

DENTSPLY SIRONA Inc. Key Details

US$3.7b

Revenue

US$1.9b

Cost of Revenue

US$1.8b

Gross Profit

US$2.4b

Other Expenses

-US$628.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-3.13
48.93%
-17.06%
170.6%
View Full Analysis

About XRAY

Founded
1877
Employees
14000
CEO
Daniel Scavilla
WebsiteView website
www.dentsplysirona.com

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

Recent XRAY News & Updates

Narrative Update Jun 01

XRAY: New Tech Partnerships And Cost Discipline Will Support Future Upside

The analyst price target for DENTSPLY SIRONA has been adjusted from $18.00 to $17.00, with analysts citing updated assumptions on revenue growth, profit margins, future P/E, and recent cautious Street research. Analyst Commentary Recent Street research on DENTSPLY SIRONA has centered on revised price targets and cautious initial views, with analysts reassessing assumptions around revenue growth, profitability, and valuation multiples.

Recent updates

No updates